Unity Biotechnology, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Unity Biotechnology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2017 to Q3 2024.
  • Unity Biotechnology, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $797K, a 53.3% decline year-over-year.
  • Unity Biotechnology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $4.46M, a 46.9% decline year-over-year.
  • Unity Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.42M, a 20.9% decline from 2022.
  • Unity Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.38M, a 18.8% decline from 2021.
  • Unity Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.6M, a 16.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.46M $797K -$908K -53.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $5.37M $974K -$1.27M -56.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $6.64M $1.39M -$781K -35.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $7.42M $1.29M -$967K -42.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 $8.39M $1.71M -$505K -22.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $8.89M $2.25M -$3K -0.13% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $8.89M $2.18M -$485K -18.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $9.38M $2.26M -$682K -23.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 $10.1M $2.21M -$876K -28.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $10.9M $2.25M -$532K -19.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $11.5M $2.66M -$84K -3.06% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $11.6M $2.94M +$241K +8.93% Oct 1, 2021 Dec 31, 2021 10-K 2024-04-15
Q3 2021 $11.3M $3.09M -$606K -16.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $11.9M $2.78M -$1.32M -32.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $13.2M $2.74M -$573K -17.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $13.8M $2.7M -$388K -12.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-15
Q3 2020 $14.2M $3.69M -$131K -3.43% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $14.3M $4.1M +$2.16M +111% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $12.2M $3.32M +$1.32M +66.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $10.9M $3.09M +$572K +22.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-15
Q3 2019 $10.3M $3.82M +$1.11M +40.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $9.17M $1.94M -$894K -31.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $10.1M $2M +$627K +45.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $9.44M $2.52M +$979K +63.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-23
Q3 2018 $8.46M $2.72M +$2.16M +386% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $6.3M $2.84M +$2.31M +441% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $3.99M $1.37M +$957K +232% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $3.03M $1.54M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-11
Q3 2017 $559K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $525K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $413K Jan 1, 2017 Mar 31, 2017 10-Q 2018-06-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.